Subscribe

Kathryn F. Mileham, MD, FACP

Articles by Kathryn F. Mileham, MD, FACP

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors

ByKathryn F. Mileham, MD, FACP,Mufti N. Ahmad, MD, FACP,Edward S. Kim, MD, FACP

April 15th 2019

In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.

Latest Updated Articles

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors
Published: April 15th 2019 | Updated:

Trending on CGTlive®

Where are the Biggest Bottlenecks in Cell and Gene Therapy?

Stephen M. Ansell, MD, PhD, on Integrating Cell Therapy into Clinical Practice in Oncology

Derek Ansel, MS, CGC, on the Growing Role of Genetic Counselors in Clinical Trials

© 2025 MJH Life Sciences^®

All rights reserved.